0001096906-16-001399.txt : 20160217 0001096906-16-001399.hdr.sgml : 20160217 20160217171758 ACCESSION NUMBER: 0001096906-16-001399 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20160216 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160217 DATE AS OF CHANGE: 20160217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DYNATRONICS CORP CENTRAL INDEX KEY: 0000720875 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 870398434 STATE OF INCORPORATION: UT FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-12697 FILM NUMBER: 161434337 BUSINESS ADDRESS: STREET 1: 7030 PARK CENTRE DRIVE STREET 2: BLDG D CITY: SALT LAKE CITY STATE: UT ZIP: 84121 BUSINESS PHONE: 8015687000 MAIL ADDRESS: STREET 1: 7030 PARK CENTER DR CITY: SALT LAKE CITY STATE: UT ZIP: 84121 FORMER COMPANY: FORMER CONFORMED NAME: DYNATRONICS LASER CORP DATE OF NAME CHANGE: 19920703 8-K 1 dynatronics.htm DYNATRONICS CORPORATION 8K 2016-02-16

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 
Date of Report (Date of earliest event reported): February 16, 2016
 
DYNATRONICS CORPORATION
(Exact name of registrant as specified in its charter)
 
Utah
0-12697
87-0398434
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification Number)
                                                          
7030 Park Centre Dr., Salt Lake City, Utah
84121
(Address of principal executive offices)
    (Zip Code)
 
Registrant's telephone number, including area code: (801) 568-7000
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 Item 2.02  Results of Operations and Financial Condition.

On February 16, 2016, Dynatronics Corporation issued a press release to report the results of its operations for the second fiscal quarter ended December 31, 2015.

Item 9.01 Financial Statements and Exhibits

A copy of the press release of the Company announcing its results of operations.

99.1
Press Release dated February 16, 2016.

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
DYNATRONICS CORPORATION
 
 
 
By:  /s/ Kelvyn H. Cullimore, Jr.
 
Kelvyn H. Cullimore, Jr.
 
Chairman and President
 
 
 
 
Date:  February 17, 2016









EX-99.1 2 exh991.htm PRESS RELEASE DATED FEBRUARY 16, 2016.
Exhibit 99.1

NEWS RELEASE

Dynatronics Announces Fiscal 2016 Second Quarter Financial Results
·
Net sales increase to $7.5 million as SolarisPlus drives organic growth
   
·
Q2 gross margin expands to 35.8% compared to 33.7% last year due to growth in high-margin proprietary therapeutic products
   
·
Regulatory approvals in Singapore and Peru extend our geographical reach for the SolarisPlus and "25 Series" product lines
   
·
Addition of seasoned healthcare executives strengthens Board of Directors
Cottonwood Heights, Utah (February 16, 2015) – Dynatronics Corporation (NASDAQ: DYNT) today announced financial and operating results for its fiscal 2016 second quarter and six months ended December 31, 2015.
Net sales for the quarter were $7.5 million, a 2.4 percent increase compared to $7.3 million in the same period of the prior year. Gross margin for the quarter was 35.8 percent, compared to 33.7 percent for the quarter ended December 31, 2014, reflecting a greater percentage of sales of proprietary therapeutic products which carry higher-than-average margins.
 "While we are in the early stages of our growth initiatives, they showed promising results this quarter," commented Kelvyn H. Cullimore Jr., chairman and chief executive officer. "Our sales team delivered double-digit growth in sales of our top-selling SolarisPlus product line which is the centerpiece of our organic growth strategy.  These high-margin proprietary products drove gross profit up by 8.7 percent in the quarter."
Net sales for the six months ended December 31, 2015, were $14.9 million, a 2.4 percent increase compared to $14.5 million in the same period of the prior year. Gross margin for the six-month period improved to 34.9 percent, compared to 34.7 percent for the six-month period ended December 31, 2014.
"We continue to benefit from a better market environment today, compared to the past several years," commented Larry K. Beardall, executive vice president of sales. "New initiatives incentivizing sales of our core modalities accounted for much of the increased sales during the quarter.  Those initiatives encouraged sales representatives to expand efforts into new accounts and markets.  In addition, the incentives promoted renewed contact with dormant former customers.
"Internationally, the recent regulatory approvals in Singapore and Peru extend our geographical reach," added Beardall. "We anticipate obtaining regulatory approvals in other foreign markets, including China and Mexico, later this year."
Net loss for the quarter ended December 31, 2015, was $124,681, compared to $133,543 for the quarter ended December 31, 2014. Net loss applicable to common shareholders for the quarter ended December 31, 2015, was $205,181, compared to $133,543 for the quarter ended December 31, 2014. Net loss for the six months ended December 31, 2015, was $306,243, compared to $92,619 for the six months ended December 31, 2014. Net loss applicable to common shareholders for the six months ended December 31, 2015, was $467,243, compared to $92,619 for the six months ended December 31, 2014. Net loss applicable to common shareholders recognizes the accrued dividends on preferred stock during the current quarter and six-month periods, which totaled $80,500 and $161,000, respectively and was payable in common stock.

"In addition to our organic growth strategy, we are implementing an M&A strategy to acquire businesses that fit a defined acquisition strategy designed to enhance our product offering, leverage our manufacturing ability and/or extend our market reach," said Cullimore. "We continue to evaluate a number of acquisition opportunities."
"During the quarter, we welcomed aboard two new directors," added Cullimore.  "David Holtz and Scott Klosterman both have excellent leadership experience in the healthcare field at Integra Lifesciences and DJO Global, respectively, and we look forward to their contributions on our board."
Dynatronics has scheduled a conference call for investors today at 4:30 p.m. ET (2:30 p.m. MT). Those wishing to participate should call (877) 471-2694 passcode 35725328.
The following is a summary of the financial results as of December 31, 2015 and 2014, and for the quarter and six months then ended:
Summary Selected Financial Data
Statement of Operations Highlights
In thousands, except per share amounts

 
     Quarter Ended         Six Months Ended     
     December 31,         December 31,     
   
2015
    2014     2015     2014  
Net sales
 
$
7,475
   
$
7,303
   
$
14,872
   
$
14,520
 
Cost of sales
   
4,798
     
4,840
     
9,684
     
9,488
 
Gross profit
   
2,677
     
2,464
     
5,188
     
5,031
 
                                 
Selling, general, and admin. expenses
   
2,469
     
2,237
     
4,825
     
4,411
 
Research and development expenses
   
254
     
235
     
519
     
452
 
Non-recurring acquisition costs
   
-
     
143
     
-
     
220
 
Other expense, net
   
73
     
75
     
150
     
118
 
Loss before income taxes
   
(119
)
   
(226
)
   
(306
)
   
(170
)
Income tax provision (benefit)
   
5
     
(92
)
   
-
     
(77
)
Net loss
 
$
(125
)
 
$
(134
)
 
$
(306
)
 
$
(93
)
8% convertible preferred stock dividend
   
(81
)
   
-
     
(161
)
   
-
 
Net loss available to common stockholders
 
$
(205
)
 
$
(134
)
 
$
(467
)
 
$
(93
)
Net loss attributable to common stockholders per share - basic and diluted
 
$
(.08
)
 
$
(.05
)
 
$
(.18
)
 
$
(.04
)

Balance Sheet Highlights
In thousands, except per share amounts

   
December 31,
 2015
   
June 30,
2015
 
         
Cash and cash equivalents
 
$
$ 2,134
   
$
3,926
 
Trade accounts receivable
   
3,017
     
3,347
 
Inventories, net
   
5,471
     
5,422
 
Total current assets
   
11,302
     
13,313
 
                 
Line of credit
   
733
     
1,910
 
Accounts payable
   
1,844
     
2,520
 
Accrued expenses
   
273
     
280
 
Accrued payroll and benefits expense
   
330
     
263
 
Total current liabilities
   
3,789
     
5,572
 


About Dynatronics Corporation:
Dynatronics manufactures, markets and sells advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, and podiatry markets. More information regarding Dynatronics is available at www.dynatronics.com.

Safe Harbor Notification
This press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements. Forward-looking statements in this press release include statements regarding expansion into new markets. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost-effective rates, and the risk factors listed from time to time in the company's SEC reports.

Contacts
Dynatronics Corporation
EVC Group
 
Bob Cardon
Chris Dailey/Michael Polyviou
 
800-874-6251 or 801-568-7000
646-445-4800
 
bobc@dynatronics.com
cdailey@evcgroup.com /
 
 
mpolyviou@evcgroup.com
 



GRAPHIC 3 image0.jpg begin 644 image0.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ HH MHH **** "BBB@ KR?XDSZYX1UJ#7=%OIH;6\.RXA^]%YH'!*GCYE';^[7K%9 M'B?0XO$?AV\TN7 ,J?NW/\#CE3^>*TI2497>Q,E=:'GN@_&F"3;#KUB86Z&X MM1^&:]+TO6=-UJV%QIM[#=1=S&V2/J.H/UKY4G@EMKB6WG0I-$YCD0 M]58'!'YT^SO;K3KE;FRN9;:=>DD3E3^E=L\+"6L=#&-5K<^MJ*\2\._&2^M- MD&O6PO(AQ]H@ 60?5>C?ABO6-$\2:1XBMO.TN]CG 'S(#AT_WE/(KCJ49PW1 MM&:EL:M%%%9%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X7\8/#G]GZ[%K4 M"8M[_P"67 X64#_V8?J#7G4,B(_[V/S(C]]0<''J#V-?3_BS08_$OAN\TQ\" M21=T+G^"0?8W&?(N%& 2.JL/X7'=?Q&1S5:VN;BRN4N;6>2"=#E9(F*L/Q%: MOAW6XM+N)+;4(/M6CW>%O+8^G9U]'7L1]*T/%G@N;P^D>HV4OV[0[D!K>[3G M:#T#^A]^A]CQ6O-9\LB+:71U'AGXQW=KLMO$,)NHNGVJ%0)!_O+T;\,'ZUZ[ MI6L:=K=FMWIMW%O*EC=G"K<#_ %,A]_[A^O'O7I:L M&4,I!4C((/!K@G"4':1T*2>PM%%%0,**** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KP?XO>' M/[,\0IJ\"8MM1^_@<+,!S^8P?J#7O%87C#P^GB;PQ=Z<<"8KO@8_PR+RO^'T M)K6A4Y)W(G'F1\OUZ=\*O%$6^3PGJP26QN\_9EE&5#'[T9SV;J/?/K7F3(\; MM'(I1T)5E/52."*5)'BD26)RDB,&1U/*D<@BO4J04XV9S1?*[GH?CWX:3:"9 M-3T='GTO[TD7WGM_\4]^H[^M>=5].^#?$*>*/"]M?MM\['E7"#M(.&_ ]?H: MX#Q_\+>9=7\.0^K3V*#\VC'_ ++^7I7-2KM/DJ;FDZ>EXGD-=AX0^(FJ>%F2 MW:9GFW=N8Q_L'M].GTKC^^#P1P0>U%=4HJ2LS--IW1]4Z#XATSQ)IXO=, MN!+'T=3P\9]&'8UJ5\I:-K>H>']12^TVX:&9>&'57']UAW%?07@OQU8>+K38 M,6^HQKF:V)_\>4]U_EWKSJV'<-5L=$*BEHSJZ***YC0**** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@#P+XM>'/[)\2C4X$Q:ZCES@<+*/O#\>#^=>?U].>-O#R^)O"UU8 #[0 M!YMNQ[2+T_/D?C7S&0RL592K*<,IZ@]Q7IX:ISPL]TE?!K6S:>(;G2 M)&_=7L>^,>DB?XKG_OD5[G7RGH&H'2O$6FWX./(N49O]W.&_0FOJRN;%QM._ M<^/OAI#KOF:IHZI#J>,R1]$N/KZ-[]^_K7AD\$UK<26]Q$\,\3%9( MW7#*1V(KZYKCO&_@"R\6VYGC*VVJ1KB.X X?_9?U'OU'Z4Z&(Y?=EL$Z=]4? M.=3V=Y17EG.\%Q"VZ.1#@J?\]JEU32[W1=1EL-0MV@N8CRK=".Q![@^M M4Z]#1HY]CZ,\!>.8/%M@8I]D.J0*/.B'1Q_?7V]NWY5V-?)NF:E=Z/J4&H6, MIBN8&W(W8^H/J#T(KZ8\+>([;Q3H,&I6_P K-\LT6>8Y!U7_ ]B*\W$4>1\ MRV.FG/FT9M4445S&@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %?/WQ7\.?V-XI-_"F+34)O"MU9HH-U&/.MC_ --%Z#\1D?C6U"IR3OT(G'F1 M\ROPC$=A7UII\39.@)@N4'SQ'^H]17SQXC\-: MEX7U,V6HQ8SDQ3+]R5?53_,=17U-6=K>AZ?XATV2PU* 2POR#T9#V93V(KHH MUW3T>QG."D?*==Q\+?$C:'XICM)7Q9:B1"X)X63^!OSX_'VK.\8^"=0\(7G[ MW,]A(V(;I1P?]EO1OY]JYC+*0R$JRG*D=CV->@^6I#R9SZQ9]>T5F^']2_M? MP[IVH9R;BW21O]XCG]-"/5=9E<)%J.I2.>BI<2,?R!J7[5XC_ .>^L_\ ? J<[9)3(A^JMD&LW4+PZCJ M=W?, #%=:/B'PQ8:J\8CDGCRZ+T# D M''MD&MBN%AN[GP/\)K*ZBMXYYK6"-Y(I&*@EV!;GU!:N/_X7?J'_ $ [7_O^ MW^%>9[&4VW!:7.GG2W/:J*\@TOXPZIJFKV>GQ:):A[F9(@?/;C)QGIV'->OU MG.G*'Q#C)2V"BO)-;^+]]I.O7^G)I%M*MK.T0D\YAN /7I5#_A=^H?\ 0#M? M^_[?X5HL-4:O87M(GM5%<_X:UV\UWPC%K,]K%;S3([QQ!R5P"0N3COBO-1\< M-1(_Y =K_P"!#?X5,:,Y-I=!N:6Y[517BP^-^HD@?V):C)QDW#?X55 M?/%IFE)/;H<"::4J7]P .!]:KZM4["]I$]=HKQ7_ (7?J'_0#M?^_P"W^%3V MWQPG\X?:]#3RN_DW!W#\Q@T?5JO87M(GL=%4='U>SUW2K?4K"0O;SKE21@CL M01V(/%UB>U45XK_PN_4/^ M@':_]_V_PJ2'XX78D'GZ%"8^_EW!!_5:/JU7L'M8GLU%8.E>+-.UCPM)K]L6 M%O%&[2H_#1E!DJ??_$5Y;=?&K4KJRFA72+>)I8V0.)V)3(QGIVJ(49R;26Q3 MG%'8R_&'PM%*Z?Z<^UBN5M^#@]1STJ%OC1X852?(U(X'_/!?_BJ\& P /2GH M561&9-ZA@2I.-PSTKM^JTS#VLCZTL[D7EE!=*CHLT:R!'&&4$9P?>IZ\5'QN MOU4*NAVH & !.W^%=OX \97OC&*^GN+"*UAMV5%*2%M[$$GJ.PQ^=</^ MF[?X4UAJC5[![2)[517FFM?%ZTTJ*""&Q^UZ@84>X59-L4+E02N[!+$9["L# M_A=^H?\ 0$M?^_[?X4+#U&KV!U(H]JHKD_\ A-[;3_!5EX@UN,6TET@9+:([ MF@((!&3QFD\/42O8:J19Z?17 M)>/?%MSX/TVUO+>SAN1--Y3+)(5Q\I((P/8UP7_"[]0_Z =K_P!_V_PJ84)S M5XH'.*=F>U45Y%IWQK+FX;4=+CB2.(M$L,I9I7R %Y& .I)]JIGXWZADXT.V MQVS<-_A5?5JG8/:1/::*\5_X7?J/_0#M?^_[?X5T'A?XNVFLZG#IVHV)L9IV M"12K)OC+'H#P",_C0\/42NT"J19Z57AWQ>\17*^+(=/M+Z>!;2W'F"*8IEW. M><'TV_G7M5Y*]O8W$T:JTD<;.H8X!(&1FO#I?BO'=RF>X\(Z3+*^"SR89C]2 M5JL-%\W,E<51JUKG#?VYJ?\ T%[[_P "G_QKVOX.Q7HU>QHZD4>U45XK_P +OU#_ * =K_W_ &_P MH_X7?J'_ $ [7_O^W^%/ZM5["]K$]JHKF? WB>?Q;H+ZE/:QVS"=H@B.6! MYR?J:RO%'Q4T?P]=R6-O$^H7D9Q(L3!4C/H6]?8 UFJ4W+E2U*YE:YW=%>+' MXWW^3C0[;';-PW^%)_PO#4/^@):_]_V_PK3ZM5[$^UB>U45XK_PO#4/^@):_ M]_V_PJ]HWQAO]4US3]/;1[=%NKF.$N)F)4,P!.,=LTGAJB5[#]I$].^,O!;0_$[3XK>,BSUBX608'"L#F4?E\WXU[G7!^$O$-QXYUZ?4_L: MV^DZ:2EJ' ,CRL,%B>V%/0?WN]=Y6M:4G:,NA$$M6@HHHK$L**** (+VRMM1 MLY;.\@2>WE7:\;C(85X'X[^'-UX8=[^P#W&D$Y+=7M_9O5?]K\_?W+5]>TK0 M;;S]4OH;9/X0[?,WT7J?PKROQ'\9)+E)+/P_IXVR#9Y]VNXMGC C]_?\JZV*ZNLWP]IQTGP[I]@0 T$"JX P-V/F M_7-:583=Y-EK1!116;X@U)='\.ZAJ+''V>!W7_>QQ^N*25W89\Z>.=3_ +7\ M;:K=!MT8F,,9']U/E'\B?QKGZ,L>6.6/)/J:='$]Q-'!$,R2L$0>I)P/YU[, M4HJQQ-W=SZ ^$FF?8/ T-PRXDO97G)[XSM7]%S^-7_B3JG]E>!-2=6VR3H+= M/JYP?TS71:99)INE6EC'C9;PI$,?[( KRKXW:GQI6DJW4M[ \AK3\.Z:=8\2:;IV,K/<(K_ .[G+?H#697HOP;TS[7XMGOV7*65 MN<'_ &WX'Z!J]"I+E@V<\5=V.O\ C-J0M?"EMIZ'#7EP,@?W$^8_KMKPNO0O MC'J?VSQA'9*/+3151WD=W\(],^W^.$N&7,=C"TQ MS_>/RK_,G\*][OKN.PL+B\E.(X(FE;Z*,G^5>;_!33/(T&_U-E^:ZG\M#C^% M!_B3^5;/Q6U/^SO EU&IQ)>.MLO/8G+?^.@UR5OWE;E^1K#W87/GRXN)+NYF MNI3F2:1I')]6.3_.FI$\\J0QC,DC!$'J2<"FUU/PYTS^U/'>FQD9C@8W+\=D M&1_X]MKT)/EBWV.=*[L>UZ_*GA3X;W*Q$#[)8B"/'=B @_4YKYJ P /2O;OC M7J?DZ'I^F*?FN9S*X_V4'^+#\J\2KGPL?U=T4U M%)F#=V?07PA@EA\ PM)G$UQ+(F?[N2C*TDLNW=L4>WKD@?C7IQ^">DHA9]9O0%&2=J?X54U3@[2DQ1YI* MZ1YAXJO-"O=9\SP[8-9V(C"[&X+OSEL9..P_"L2GS",3R"%F:$.1&S=2N>"? M?%1DX!-=4596,F>X_"728KSP#>Q7T0EM;VZ<&-LX90%4_J#6%\5]#\/^'M-T M^#2]+M[:ZN9BQ=,Y"*.1U[EA^5>H>$=+_L;PEI=@1AX[=2_^^?F;]2:\7^+F MI_;_ !N]LK9CL85A&/[Q^9OY@?A7#2;G6;6QO)6@<)7(O$5Q_:-N MMQ9VUON:-\X+L<+_ "8UP]>Z_!C3/LOA6XU!EP][<'!]43Y1^NZNG$3Y:;:, MZ:O(Z'_A77A#_H VO_CW^-:ECIFE>&=,G6PM8[2U3=-(J=,XY/Y"M.N0^)NI M_P!F> ]0*MMDN0+9,?[9P?\ QW=7G)RFU%LZ'9*Y\\W]X^HZC=7TGW[F9YC_ M ,")/]:K\YP 23T [T5T7@33/[7\;Z5;%=T:S>=(#TVI\W\P!^->LVHQOV.1 M:LZK3/@OJUW:1SWVHP6;NN[R1&9&7/9CD#/YU+>?!'44BS:ZO;SG(#(\1CX[ MX.3SBO;*9+*D$,DTAVI&I9CZ G: MDJWWW:YD'L!M7]2?RK@A.4ZVCT-VE&!X[6]X)L&U+QMH]NHR!Y^5?Y-7D]=-\0=3_M7QUJDX.8XI/LZ?1!M_GFN9I48\M-()N\F>C_ I\ M(:=XAEU"]U6V%Q;VY6**-B0I<\DG'7 Q^==YXA\$^#M,\.:C?-HMNGD6[N&4 ML""!Q@YZYQ5CX6Z9_9O@.R9EQ)=EKE\C^\?E_P#'0M9WQBU/['X.2R5L/?3J MA'JB_,?Y#\ZXY3E.M9/J;))0NSP09VC/7'-7=)@DNM:T^WASYLES&JX]=PJG M7;?"G3/[1\=V\K+F.RC>X;Z_=7]6S^%=TY:^9 , =J]H^-NI^7I>FZ4K]5FLK>(S3*K8W<@*N??)3;1$%>1U(^'/A #']@VO\ MX]_C2/\ #?P@ZX.A6X]U9@?T-=317F>TGW9UM+R[\%?Z)$\JQ7*23*@R=@!YQZ D M5\^[U_O#\Z[\+K%RZLYZN]C0T>YL;/6+6XU*T:\LXWW2VZD#>,' Y]\5WO\ MPFW@+_H1U_[]Q_XUYEO3^\OYTH8'H0?I6TJ:D[LA2:/3/^$V\!?]".O_ '[C M_P :Z7PG!X"\4ZE%=:1IKV&I6,BW'E#UP"59:=(4444 %%%% !1110 4444 %% M5K_4+/2[*2\OKB.WMXQEI)&P!_\ 7]J\4\9?%>\U;S+'0C)9V1^5K@\2RCV_ MN#]?I6M.E*H]"934=SNO&7Q,T[PWYEG9;;[5!P8U;Y(C_MD=_8<_2O$KW4-9 M\7ZY$;F5[R^N'$<*=%7)Z*.BC_)K)Z9)^I->W?"GP0VF6XU_4HBMY.F+:-AS M%&?XC_M-^@^IKMY88>-^IA=U'8[CPQH,'AKP]:Z7#AC$N9' ^^YY9OS_ $Q6 MO117G-MN[.E*P45RWB'X@^'_ YNCN+L7%VO_+M;?.^??LOXFO*/$/Q8U[6- MT-@1IEJ>,1',I'N_;\ *UIT)S(E4C$]DU[Q?H?AN/.I7R)+C*P)\TC?11S^) MXKRGQ#\8]4OM\&B6XL(3QYTF'E/T'1?UKS5V:21I'9G=CEF8Y)/N>])7;3PT M([ZF,JK>Q+=75Q?7+7-W/+<3O]Z25RS'\37;?"SPNVN>)%U">/\ T'3V$C$C MAY>JK^'WC]!ZUS?AOPW?^*=72PL4Q_%-,1\L*>I_H.]?2NA:)9^'M'@TVQ3; M#$.6/WG8]6/J32Q%50CRK<*<+N[-&BBBO-.D*\X^,FKK:>%H=,5\37TPRH/_ M "S3YC^NT5Z/6!K/@O0/$%Z+S5+(W$X0(K&9P%4=@ <"M*4HQFG(F2;5D?,- M6M,OGTO5+6_BCCDDMI1*B2 E21TSBOH/_A5W@[_H$#_O_)_\51_PJ[P=_P! M@?\ ?^3_ .*KM>+IOHS'V4CSG_A=/B+_ )\M-_[X?_XJN+U_7K[Q)JSZCJ#( M9F4(%085%'0 ?B?SKWK_ (5=X._Z! _[_P G_P 52CX7^#@<_P!CJ?K-)_\ M%5$:]&+O&(W";W9\Z0Q2W$Z001O+-(=J1HN68^@%?1?PZ\*OX6\.".Z %_=- MYUQ@YVG& F?8?J36UI7AO1=#R=,TRVMF/!=$^8_\"/-7[N[@L+.:[N7$<$"& M21R,[5 R365;$.HN5+0N%/EU9\Y?$BUGM?'^J>>I'G.LL1/1D*@ C\B/PKE: M^F+V?P;XILXQ>W.E7T0Y0O,NY?H>:R/&WCNX\9"S1[);.WMR MSJ@D+EV/&3NOCC_ -#KQKQ9?6FH>)[V73TC M2PC80VJQ+A1&@P,#T/)_&JI>SG/FC'44N9*S9BUZY\$=,S+JNK,O0+;1G_QY MO_9:\CZ#)KZ.^'&CG3/ -E#*K)+=*UQ)@X(W\CZ';MIXJ5J=NX4E>1Y1\5M8 M35?&TL43AH;&,6X(Z;NK?J('VSW@^S1 'D[OO?DN:Z#1="T[P]9-9Z7;^1;LYD*;V;YCC)Y)]*JZWX M1T3Q'/%-JUHUPT2E8\S.H4'K@ @?C7,YQ=7G>QIRM1LCY=K>\$V*:EXVT>VD M *&X#L#W" MC_P =KV__ (5=X._Z! _[_P G_P 55FP^'OAC2]0@OK+3?*N8 M&W1N)I#@_BU=4L7!II7,E2=SA_CB\V-$3!\C=*<]M^%Q^F?UKR&OK+4=,L=7 MLVM-0M(KF!CDI*N1GU]C[US;?##P#O^@0/^_\ )_\ %5?MO OAFSL[JUM])ACCNH_*F(+; MF7TW9R!]#1*M1D^9QU!0FE:Y\Q@8&!VK6\+Z>NJ^*]*L7^Y+,$GC\::TMRI$OVR1B#Z$Y4_3&*^HZQ]8\*:%K[K)JFF07$BC M D(*N!Z;A@XKFH553=V:SCS(^6J])\/?%I]!T"STH:&DJVT>P.MQMW>^-IY- M>B?\*N\'?] @?]_Y/_BJ/^%7>#O^@0/^_P#)_P#%5T3Q%*:M),S5.:V9RNG? M%K5=>UBSTO3=%MX9KF4)OEF:0(.K-@ =!D_A53XUZPDESIVBQOEH@;B8 ]"> M%!_#B:/X'\.Z#?B^TW3EAN0I02>8[8!Z]2:@O?AWX7U&]FO+S3C-<3- MODD:>3+'_OJLHU*49J26B*<9.-FSYJKU+X)6"RZSJE^P!:"!(D]MY)/_ *"* M[O\ X5=X._Z! _[_ ,G_ ,56MH?A/1?#$;N9I9-$@5V.3Y3-&/ MR4@5!_PJ[P=_T"!_W_D_^*KT/K<.S.?V4CCO^%XR?]"^/_ O_P"PKS[Q5XEN M?%>MMJ5S$L/R"..)6R$49[]SDDU[E_PJ[P=_T"!_W_D_^*H_X5=X._Z! _[_ M ,G_ ,56<*U&#O%/^OF4X3>C9\Y=P "23@ #DFO>_"5E_P (#\-;G4-04173 MJUU*C=0Q&$3Z_='U)KI-+\%>&]&N%N+#2+>*=?NR$%V7Z%B33HHC< M3Q0 X,KK&#]3C^M?17_"KO!W_0('_?\ D_\ BJ4?##P>K!ETG# Y!$\G!_[Z MK;ZW#LR/8R.IM;:.SLX+6(8CAC6-![ 8%>&_&+6$O_%,&GQ/NCL(:72S)+(Q9W:XD)8GDDG=7)1G&$N:1K.+:LCYOKV M7X(6*+8:MJ) WO,L /H%&3^K?I74?\*N\'?] @?]_P"3_P"*K9T?PQI.@VEQ M:Z7;-;0W!S(%EMB8SARHB%-IW9X7\4=835_&]PL3[X;-!;* M1TR,EO\ QXD?A7&U]'?\*O\ !_?2 ?8_>75TQ)]EPH'Z'\Z\K^($5Q#X^UD7*L&>? M>F>Z$#:1[8_E7T1HVAZ?X?L?L6F0>1;[R^S>S'-&U]4&JZ=!=%. M%9U^9?HPY%8PKJ-1SZ,MPO%(^5J]"\*_%.;PSH,.E'2([A(2VV19MA.6)Y&# MSS7IG_"K_!W_ $!Q_P!_Y/\ XJD_X5=X._Z! _[_ ,G_ ,56T\12FK23(5.2 MV9QI^.,F./#ZY][O_P"PKH/ WCC6/&>LSAK*WM-.M8\R%279W;[JY. .A/3L M*TO^%7>#O^@0/^_\G_Q5;NB>']+\.VLEMI5HMO%(_F. Q8EL8SDDGM6$YT>7 MW(ZEI3OJSSS6?BU=Z%XKU+39=-ANK6WFV1LLAC M$E9CU):,Y_\ ':[R]^'?A;4;Z>]NM+$EQ.YDD?SI!N8]3PU5_P#A5W@[_H$# M_O\ R?\ Q54IT+:I_P!?,5I]SBO^%M:%_P!"@GYQ_P#Q-T:ST MB+3H[=6SMV[I"<=2 .!C]37LO_"KO!W_ $"!_P!_Y/\ XJC_ (5=X._Z! _[ M_P G_P 55QK48NZ3_KYB<)M6;/G( LRJH+,QPJ@9)/H!7T/\,/#$_ASPTS7L M9CO;V3SI(SU1<853[XY/UK:TGP?X>T2;SM.TFWAF'27!9Q]"V2*W*BOB/:+E M6PX4^5W84445RFH4444 %%%% !114<\\5M \\\J111C<[NP"J/4DT 25RGB[ MQ]I7A.(Q2-]IU C*6D9Y^K'^$?KZ"N'\9?%QI/,L/#)*KRKW[#D_]LS&=6VB-?Q'XIU7Q3>_:-2GRBG, M5NG$<7T'K[GFL:CJ0 "23@ =Z]8\#_#2."--=\5*D,,8WQ6DQ"@>C2Y_]!_/ MTKKE.-*)DDY,B^&OP[:]DAU[6H2+52'M;9Q_K3V=A_=]!WZ].OM)(52S$ 9 M)/:O.?$'Q?T;30T&D1G4IQP'4[85_P"!=3^ _&O*?$'C77O$I9;Z]9;(?$&^(W/V*T;CR+4E+KH?9U,%BK8ENW7Y1ZA?[S>W MYUW'A+X/$F.\\2L,=5L8F_\ 0V'\A^=>MV]O#:6\=O;1)##&-J1HH"J/0 5R M5<4EI UA2;U9G^'_ [IWAG3%L=.AV(.7=N7D;^\Q[FM6BBN!MMW9T+0**** M0!1110 4444 %%%% !6/XKT^[U7PKJ5A8[/M-Q 8TWMM'/')^E;%%-.SN#U/ MGT_!WQ2>L>GG_MO_ /8TG_"G/%/_ #RT_P#[_P#_ -C7T'171];J&7LHGS[_ M ,*=\4_\\M/_ .__ /\ 8TO_ I_Q7_=L?\ P(/_ ,37T#11];J![*)Y%X9^ M#;P7L5UX@NH98XR&%I!DAR/[S'''L!SZUZX , = *6BL9U)3=Y%QBH[!1 M114%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 44C,%4LQ 4#))[5Y=XR^+5O8^98>'2ES/Z?6KA3E-VB*4E%:G9^)_&&D^%+3S;^;=.XS%;1\R2?AV'N>*\&\5^- M]6\6SD7+^18JA;^\?K^ K N[NYO[N2ZO)Y)[B0Y>21LL:AKT:6'C M3UW9S3J.05+;V\ES*(X]@[EG8*JCU)/ %145N0=9IFM:-X3(GTZV75]8'2[N M%*V\!_Z9I]YC_M''M6/K7B36/$4WF:I?2S@'*Q9VQK]%'%9=%2H)._4=W:P4 M4$@#).*VM%\(Z]X@(_L[39GC/_+9QLC'_ CU_#-4VDKL23>QBU+:VMQ>W*VU MI!+<3OPL<2%F/X"O7M"^"L*;9=>U RGJ;>U^5?Q<\G\ *]*TG0]+T.W\C3+& M&U3OY:\M]3U/XURSQ4%\.IK&DWN>/>'/@[J5]LGUR<6$!Y\B,AI2/<]%_6O6 M]"\-:1X;MO(TNS2'(^>3J[_[S'DUK45QU*TY[FT8*.P4445D4%%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !67KOB'3/# M=@;O4[E8DZ(@Y>0^BCN:Y+QG\4;#0?,L=+V7VI#AL',4)_VB.I]A^.*\/U35 MK_6[][W4KI[BX?\ B;HH]%'0#V%=5+#.>LM$93J):(Z;QA\1M4\4L]M#NLM, M/'D(WS2#_;/?Z#CZUQM%%>A&*BK(P;;=V%%3VEG=ZA*(K*UGN9#_ PQES^E M=9IGPL\5ZCM9[*.RC/\ %=2 $?\ 1DTI3C'=@DWL<92$@=3BO9]+^"5HFU] M6U::8]X[9!&OYG)_E7;:3X'\-:+M:STFW\P?\M91YC_FVVAHJ26YRNB_#KPSHA5X=.6XG7I-='S&_7@?@*ZD 8 Z M 4M%<\I.3NV:));!1114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH IZGJMCHUC)>ZC:Z(2IT]6KLSDI2V/FFPT#6-3P+# M2KRX'K'"VW\^E=3I_P )/%5[M,T-M9(>\\P)'X+FOH3I15RQDGLA*BNIY-IW MP1MEVMJ>L32>J6T80?F<_P JZW3?AKX3TW:RZ4EQ(O\ '=,93^1X_2NLHK&5 M:I+=EJ$5T(X+>"UB$5O#'%&.BQJ% _ 5)116104444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '!1110!__V0$! end